France· FR:69430342
ACCUSOL 35, solution pour hémofiltration, hémodialyse et hémodiafiltration
A medicinal product, registered in France by NIKKISO BELGIUM (BELGIQUE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- NIKKISO BELGIUM (BELGIQUE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009374771612 poche(s) (CLEARFLEX) bicompartimenté(e)(s)/à 2 compartiments polypropylène polyamide SEBS : styrène-éthylène-butylène-styrène polyéthylène suremballée(s)/surpochée(s) de 5000 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ACCUSOL in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandAccusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvba
- FinlandBicanova 1.5 % GlukoosiFresenius Medical Care Deutschland GmbH
- CanadaPHYSIONEAL 40 GLUCOSE 3.86%VANTIVE ULC
- SpainACCUSOL 35 SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACIONNikkiso Belgium
- CzechiaDUOSOL BEZ KALIAB.Braun Avitum AG, Melsungen
- GermanyAccusol 35Nikkiso Belgium
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Belgium · Accusol 35
- Germany · Accusol 35
- Spain · Accusol 35
- United Kingdom (Northern Ireland) · Accusol 35
- Greece · Accusol 35, Vermalton
- Ireland · Accusol 35
- Slovakia · Accusol 35
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9b742e8-d1c0-4496-b01c-7e146c90cd61 GET /v1/drugs/b9b742e8-d1c0-4496-b01c-7e146c90cd61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69430342",
"date_amm": "2006-05-15",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution et solution pour hémofiltration pour hémodialyse et pour hémodiafiltration",
"voies_administration": "hémodialyse;hémofiltration",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ACCUSOL.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.